# A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0

> **NCT01284491** · NA · TERMINATED · sponsor: **Medtronic Surgical Technologies** · enrollment: 13 (actual)

## Conditions studied

- Macromastia

## Interventions

- **DEVICE:** PEAK PlasmaBlade 4.0
- **DEVICE:** Traditional Electrosurgery with scalpel

## Key facts

- **NCT ID:** NCT01284491
- **Lead sponsor:** Medtronic Surgical Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Termination due to acquisition of PEAK Surgical by Medtronic
- **Last updated:** 2013-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01284491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01284491, "A Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01284491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*